ZA907648B - Use of a polypeptide having the activity of human interleukine 2 for the preparation of pharmaceutical compositions intended for the treatment of leukemias - Google Patents
Use of a polypeptide having the activity of human interleukine 2 for the preparation of pharmaceutical compositions intended for the treatment of leukemiasInfo
- Publication number
- ZA907648B ZA907648B ZA907648A ZA907648A ZA907648B ZA 907648 B ZA907648 B ZA 907648B ZA 907648 A ZA907648 A ZA 907648A ZA 907648 A ZA907648 A ZA 907648A ZA 907648 B ZA907648 B ZA 907648B
- Authority
- ZA
- South Africa
- Prior art keywords
- polypeptide
- activity
- leukaemias
- human
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2013—IL-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8913546A FR2653020B1 (fr) | 1989-10-17 | 1989-10-17 | Utilisation d'un polypeptide ayant l'activite de l'interleukine 2 humaine pour la preparation de compositions pharmaceutiques destinees au traitement des leucemies. |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA907648B true ZA907648B (en) | 1991-11-27 |
Family
ID=9386473
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA907648A ZA907648B (en) | 1989-10-17 | 1990-09-25 | Use of a polypeptide having the activity of human interleukine 2 for the preparation of pharmaceutical compositions intended for the treatment of leukemias |
Country Status (13)
Country | Link |
---|---|
US (1) | US5582822A (hu) |
EP (1) | EP0426521B1 (hu) |
JP (1) | JP2961189B2 (hu) |
KR (1) | KR0168420B1 (hu) |
AT (1) | ATE103494T1 (hu) |
AU (1) | AU640173B2 (hu) |
CA (1) | CA2027725A1 (hu) |
DE (1) | DE69007744T2 (hu) |
DK (1) | DK0426521T3 (hu) |
FR (1) | FR2653020B1 (hu) |
HU (1) | HU206048B (hu) |
OA (1) | OA09317A (hu) |
ZA (1) | ZA907648B (hu) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2671728B1 (fr) * | 1991-01-17 | 1995-01-20 | Roussel Uclaf | Utilisation d'un polypeptide ayant l'activite de l'interleukine 2 humaine pour la preparation de compositions pharmaceutiques destinees au traitement des pneumathorax. |
FR2686899B1 (fr) | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
US5696079A (en) * | 1993-05-19 | 1997-12-09 | The United States Of America As Represented By The Department Of Health And Human Services | Immunologic enhancement with intermittent interleukin-2 therapy |
US5419900A (en) * | 1993-05-19 | 1995-05-30 | The United States Of America As Represented By The Department Of Of Health And Human Services | Immunologic enhancement with intermittent interleukin-2 therapy |
WO2001077137A1 (en) | 2000-04-12 | 2001-10-18 | Human Genome Sciences, Inc. | Albumin fusion proteins |
US6852344B2 (en) * | 2000-12-04 | 2005-02-08 | Council Of Scientific And Industrial Research | Herbal composition for treating CD33+ acute and chronic myeloid leukemia and a method thereof |
GB2372598A (en) * | 2001-02-26 | 2002-08-28 | Coppereye Ltd | Organising data in a database |
JP5424521B2 (ja) | 2001-12-21 | 2014-02-26 | ヒューマン ジノーム サイエンシーズ, インコーポレイテッド | アルブミン融合タンパク質 |
EP1511475B1 (en) * | 2002-05-31 | 2005-10-05 | Council of Scientific and Industrial Research | A herbal molecule as potential anti-leukemic drug |
US6967034B2 (en) * | 2002-05-31 | 2005-11-22 | Council Of Scientific And Industrial Research | Herbal-based composition for treating acute and chronic myeloid leukemia |
US20040006138A1 (en) * | 2002-07-08 | 2004-01-08 | Council Of Scientific | Pharmaceutical composition useful for treating chronic myeloid leukemia |
US20050282892A1 (en) * | 2002-07-08 | 2005-12-22 | Santu Bandyopadhyay | Pharmaceutical composition useful for treating chronic myeloid leukemia |
US20070161704A1 (en) * | 2002-07-08 | 2007-07-12 | Council Of Scientific And Industrial Research | Pharmaceutical composition useful for treating chronic myeloid leukemia |
WO2004024171A1 (en) * | 2002-09-16 | 2004-03-25 | Vasogen Ireland Limited | Chronic lymphocytic leukemia combination treatment (treated cll cells and cytokine) |
EP1594530A4 (en) | 2003-01-22 | 2006-10-11 | Human Genome Sciences Inc | HYBRID PROTEINS OF ALBUMIN |
US7357652B1 (en) * | 2006-10-27 | 2008-04-15 | Leviton Manufacturing Company, Inc. | Modular wiring system with locking elements |
US8206920B2 (en) * | 2007-03-26 | 2012-06-26 | Arnold Ganser | Diagnostic assay for the specific treatment of acute myeloid leukemia |
US10622768B1 (en) | 2019-05-10 | 2020-04-14 | Walter Morgan Cowham | Methods and systems for a modular plug-in bus wiring system |
US10971879B1 (en) | 2020-08-12 | 2021-04-06 | Cowham Innovations, LLC. | Electrical connection forming tool |
CN111821423B (zh) * | 2020-08-17 | 2023-04-11 | 中南大学湘雅二医院 | 一种白介素2用于治疗慢性自发性荨麻疹的应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8701004D0 (sv) * | 1987-03-11 | 1987-03-11 | Astra Ab | Method for therapy of leukemias and certain other malignancies |
PT89121A (pt) * | 1987-12-04 | 1989-12-29 | Du Pont | Processo para a preparacao de interleuquina-2 imobilizada e interleuquina-2 contendo uma extensao no terminal-carboxilo com actividade de interleuquina-2 natural |
ZA898139B (en) * | 1988-11-17 | 1990-08-29 | Hoffmann La Roche | Recombinant interleukin-2 hybrid proteins |
-
1989
- 1989-10-17 FR FR8913546A patent/FR2653020B1/fr not_active Expired - Fee Related
-
1990
- 1990-09-25 ZA ZA907648A patent/ZA907648B/xx unknown
- 1990-10-16 KR KR1019900016445A patent/KR0168420B1/ko not_active IP Right Cessation
- 1990-10-16 DE DE69007744T patent/DE69007744T2/de not_active Expired - Lifetime
- 1990-10-16 DK DK90402900.6T patent/DK0426521T3/da active
- 1990-10-16 AT AT90402900T patent/ATE103494T1/de not_active IP Right Cessation
- 1990-10-16 HU HU906463A patent/HU206048B/hu not_active IP Right Cessation
- 1990-10-16 CA CA002027725A patent/CA2027725A1/fr not_active Abandoned
- 1990-10-16 EP EP90402900A patent/EP0426521B1/fr not_active Expired - Lifetime
- 1990-10-17 JP JP2276591A patent/JP2961189B2/ja not_active Expired - Lifetime
- 1990-10-17 AU AU64667/90A patent/AU640173B2/en not_active Ceased
- 1990-10-17 OA OA59870A patent/OA09317A/xx unknown
-
1994
- 1994-09-30 US US08/315,890 patent/US5582822A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0426521B1 (fr) | 1994-03-30 |
HUT55241A (en) | 1991-05-28 |
HU206048B (en) | 1992-08-28 |
CA2027725A1 (fr) | 1991-04-18 |
OA09317A (fr) | 1992-09-15 |
HU906463D0 (en) | 1991-04-29 |
FR2653020A1 (fr) | 1991-04-19 |
DE69007744D1 (de) | 1994-05-05 |
EP0426521A1 (fr) | 1991-05-08 |
JPH03193736A (ja) | 1991-08-23 |
KR910007541A (ko) | 1991-05-30 |
US5582822A (en) | 1996-12-10 |
JP2961189B2 (ja) | 1999-10-12 |
KR0168420B1 (ko) | 1999-01-15 |
FR2653020B1 (fr) | 1993-03-26 |
DE69007744T2 (de) | 1994-07-28 |
AU640173B2 (en) | 1993-08-19 |
ATE103494T1 (de) | 1994-04-15 |
AU6466790A (en) | 1991-04-26 |
DK0426521T3 (da) | 1994-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA907648B (en) | Use of a polypeptide having the activity of human interleukine 2 for the preparation of pharmaceutical compositions intended for the treatment of leukemias | |
HUT38125A (en) | Process for preparing lymphokines /cytotoxic factors/ and pharmaceutical compositions containing such active substance | |
EP0433827A3 (en) | Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto | |
HK65693A (en) | Pharmaceutical composition containing a human granulocyte colony stimulating factor for the treatment of leukopenia | |
IL102346A0 (en) | Cysteine depleted il-6 muteins | |
EP0231819A3 (en) | Pharmaceutical agent for the treatment of myelogenous leukemia | |
EP0553294A4 (en) | Methods and compositions for the treatment of cell proliferation disorders | |
ZA904353B (en) | Use of a polypeptide having the activity of human interleukin 2 for preparing a pharmaceutical composition intended for the treatment of primary cancers of the pleura | |
IL89662A0 (en) | Pharmaceutical compositions comprising interferon-beta 1 | |
IE871358L (en) | Interferon for carcinoma | |
ZA919682B (en) | Use of a polypeptide having human interleukin 2 activity for the preparation of pharmaceutical compositions for the treatment of pneumothorax | |
IL96229A0 (en) | Use of a polypeptide having the activity of gamma interferon for the preparation of pharmaceutical compositions intended for the treatment of primary cancers of the pleura | |
HU900202D0 (en) | Process for manufacturing of pharmaceutical compositions comprising gamma-interferon suitable to treatment of ovarion cancer |